170 related articles for article (PubMed ID: 26918396)
1. Active-Site-Directed Inhibitors of Prolyl Oligopeptidase Abolish Its Conformational Dynamics.
López A; Herranz-Trillo F; Kotev M; Gairí M; Guallar V; Bernadó P; Millet O; Tarragó T; Giralt E
Chembiochem; 2016 May; 17(10):913-7. PubMed ID: 26918396
[TBL] [Abstract][Full Text] [Related]
2. 15N relaxation NMR studies of prolyl oligopeptidase, an 80 kDa enzyme, reveal a pre-existing equilibrium between different conformational states.
Kichik N; Tarragó T; Claasen B; Gairí M; Millet O; Giralt E
Chembiochem; 2011 Dec; 12(18):2737-9. PubMed ID: 22069228
[TBL] [Abstract][Full Text] [Related]
3. Molecular dynamics, crystallography and mutagenesis studies on the substrate gating mechanism of prolyl oligopeptidase.
Kaszuba K; Róg T; Danne R; Canning P; Fülöp V; Juhász T; Szeltner Z; St Pierre JF; García-Horsman A; Männistö PT; Karttunen M; Hokkanen J; Bunker A
Biochimie; 2012 Jun; 94(6):1398-411. PubMed ID: 22484394
[TBL] [Abstract][Full Text] [Related]
4. Decoding the structural events in substrate-gating mechanism of eukaryotic prolyl oligopeptidase using normal mode analysis and molecular dynamics simulations.
Kaushik S; Etchebest C; Sowdhamini R
Proteins; 2014 Jul; 82(7):1428-43. PubMed ID: 24500901
[TBL] [Abstract][Full Text] [Related]
5. Crystal Structure and Conformational Dynamics of Pyrococcus furiosus Prolyl Oligopeptidase.
Ellis-Guardiola K; Rui H; Beckner RL; Srivastava P; Sukumar N; Roux B; Lewis JC
Biochemistry; 2019 Mar; 58(12):1616-1626. PubMed ID: 30786206
[TBL] [Abstract][Full Text] [Related]
6. Dynamics and ligand-induced conformational changes in human prolyl oligopeptidase analyzed by hydrogen/deuterium exchange mass spectrometry.
Tsirigotaki A; Elzen RV; Veken PV; Lambeir AM; Economou A
Sci Rep; 2017 May; 7(1):2456. PubMed ID: 28550305
[TBL] [Abstract][Full Text] [Related]
7. Analyzing slowly exchanging protein conformations by ion mobility mass spectrometry: study of the dynamic equilibrium of prolyl oligopeptidase.
López A; Vilaseca M; Madurga S; Varese M; Tarragó T; Giralt E
J Mass Spectrom; 2016 Jul; 51(7):504-11. PubMed ID: 27434808
[TBL] [Abstract][Full Text] [Related]
8. Molecular dynamics study of prolyl oligopeptidase with inhibitor in binding cavity.
Kaszuba K; Rog T; St Pierre JF; Mannisto PT; Karttunen M; Bunker A
SAR QSAR Environ Res; 2009 Oct; 20(7-8):595-609. PubMed ID: 20024801
[TBL] [Abstract][Full Text] [Related]
9. Flexibility of prolyl oligopeptidase: molecular dynamics and molecular framework analysis of the potential substrate pathways.
Fuxreiter M; Magyar C; Juhász T; Szeltner Z; Polgár L; Simon I
Proteins; 2005 Aug; 60(3):504-12. PubMed ID: 15971204
[TBL] [Abstract][Full Text] [Related]
10. Enzyme dynamics from NMR spectroscopy.
Palmer AG
Acc Chem Res; 2015 Feb; 48(2):457-65. PubMed ID: 25574774
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of prolyl oligopeptidase with a synthetic unnatural dipeptide.
Racys DT; Rea D; Fülöp V; Wills M
Bioorg Med Chem; 2010 Jul; 18(13):4775-82. PubMed ID: 20627594
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence resonance energy transfer (FRET) peptides and cycloretro-inverso peptides derived from bradykinin as substrates and inhibitors of prolyl oligopeptidase.
Gorrão SS; Hemerly JP; Lima AR; Melo RL; Szeltner Z; Polgár L; Juliano MA; Juliano L
Peptides; 2007 Nov; 28(11):2146-54. PubMed ID: 17904692
[TBL] [Abstract][Full Text] [Related]
13. The loops facing the active site of prolyl oligopeptidase are crucial components in substrate gating and specificity.
Szeltner Z; Juhász T; Szamosi I; Rea D; Fülöp V; Módos K; Juliano L; Polgár L
Biochim Biophys Acta; 2013 Jan; 1834(1):98-111. PubMed ID: 22940581
[TBL] [Abstract][Full Text] [Related]
14. Molecular, functional and structural properties of the prolyl oligopeptidase of Trypanosoma cruzi (POP Tc80), which is required for parasite entry into mammalian cells.
Bastos IM; Grellier P; Martins NF; Cadavid-Restrepo G; de Souza-Ault MR; Augustyns K; Teixeira AR; Schrével J; Maigret B; da Silveira JF; Santana JM
Biochem J; 2005 May; 388(Pt 1):29-38. PubMed ID: 15581422
[TBL] [Abstract][Full Text] [Related]
15. Prolyl oligopeptidase structure and dynamics.
Rea D; Fülöp V
CNS Neurol Disord Drug Targets; 2011 May; 10(3):306-10. PubMed ID: 21222626
[TBL] [Abstract][Full Text] [Related]
16. Structure, function and biological relevance of prolyl oligopeptidase.
Szeltner Z; Polgár L
Curr Protein Pept Sci; 2008 Feb; 9(1):96-107. PubMed ID: 18336325
[TBL] [Abstract][Full Text] [Related]
17. Conformational heterogeneity of UCAAUC RNA oligonucleotide from molecular dynamics simulations, SAXS, and NMR experiments.
Bergonzo C; Grishaev A; Bottaro S
RNA; 2022 Jul; 28(7):937-946. PubMed ID: 35483823
[TBL] [Abstract][Full Text] [Related]
18. Study of the Conformational Dynamics of Prolyl Oligopeptidase by Mass Spectrometry: Lessons Learned.
Van Elzen R; Konijnenberg A; Van der Veken P; Edgeworth MJ; Scrivens JH; Fülöp V; Sobott F; Lambeir AM
J Med Chem; 2024 Jun; 67(12):10436-10446. PubMed ID: 38783480
[TBL] [Abstract][Full Text] [Related]
19. Substrate- and pH-dependent contribution of oxyanion binding site to the catalysis of prolyl oligopeptidase, a paradigm of the serine oligopeptidase family.
Szeltner Z; Renner V; Polgár L
Protein Sci; 2000 Feb; 9(2):353-60. PubMed ID: 10716187
[TBL] [Abstract][Full Text] [Related]
20. Unclosed beta-propellers display stable structures: implications for substrate access to the active site of prolyl oligopeptidase.
Juhász T; Szeltner Z; Fülöp V; Polgár L
J Mol Biol; 2005 Feb; 346(3):907-17. PubMed ID: 15713471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
